Submit your claim details for a free, no obligation case review
Get Started:
Pfizer''s Parke-Davis unit sells Neurontin, a large selling epilepsy drug. The company is currently facing a lawsuit over the marketing of Neurontin after a former employee has accused the company of giving doctors misleading information and kickbacks to promote the drug for uses not FDA approved. Pfizer announced March 10, 2004 that the U.S. Department of Justice is investigating its marketing of a growth hormone treatment called Genotropin and a painkiller called Bextra as well. A grand jury has also inquired about the company''s diabetes drug Rezulin that was acquired when Pfizer bought Warner-Lambert.